Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Accepts healthy volunteers Results available

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

ClinicalTrials.gov ID: NCT01887912

Public ClinicalTrials.gov record NCT01887912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection (Cdiffense™)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this study was to evaluate the efficacy of the Clostridium difficile vaccine to prevent primary symptomatic C. difficile infection (CDI) in participants at risk for CDI where there is a substantial unmet medical need. Primary objective: * To assess the efficacy of the C. difficile vaccine in preventing the onset of symptomatic primary CDI confirmed by polymerase chain reaction (PCR) in adult participants aged \>= 50 years who are at risk for CDI and have received at least 1 injection. Secondary Objectives: Efficacy: * To assess prevention of symptomatic PCR-confirmed primary CDI cases after 3 injections administered at 0, 7, and 30 days. * To assess prevention of symptomatic PCR-confirmed primary CDI cases after completion of at least 2 injections. Immunogenicity: * To describe the immunogenicity to toxin A and toxin B at specific time points in a subset of participant and in participants with CDI at Day 0 and Day 60. Safety: * To describe the safety profile of all participants who received at least 1 injection.

Study identification

NCT ID
NCT01887912
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
9,302 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 29, 2013
Primary completion
Jun 11, 2018
Completion
Jun 11, 2018
Last update posted
Mar 27, 2022

2013 – 2018

United States locations

U.S. sites
142
U.S. states
37
U.S. cities
127
Facility City State ZIP Site status
Not listed Huntsville Alabama 35803
Investigational Site 104 Mobile Alabama 36608
Not listed Flagstaff Arizona 86001
Investigational Site 194 Phoenix Arizona 85018
Investigational Site 503 Surprise Arizona 85374
Not listed Little Rock Arkansas 72205
Not listed Bakersfield California 93301
Not listed Banning California 92220
Not listed Garden Grove California 92844
Not listed La Mesa California 91942
Investigational Site 534 Los Angeles California 90022
Investigational Site 051 Los Angeles California 90027
Not listed Modesto California 95350
Not listed Redding California 96001
Not listed Sacramento California 95817
Investigational Site 504 Simi Valley California 93065
Investigational Site 057 Stanford California 94305
Investigational Site 176 Upland California 91786
Not listed Ventura California 93003
Investigational Site 546 Wheat Ridge Colorado 90033
Not listed Bristol Connecticut 06010
Not listed Danbury Connecticut 06810
Investigational Site 143 Bradenton Florida 34209
Investigational Site 187 Brandon Florida 33511
Investigational Site 075 Clearwater Florida 33756
Investigational Site 517 Clearwater Florida 33765
Investigational Site 055 Crystal River Florida 34429
Not listed DeLand Florida 32720
Investigational Site 506 Gainesville Florida 32607
Investigational Site 099 Hialeah Florida 33012
Investigational Site 009 Jacksonville Florida 32216
Not listed Lauderdale Lakes Florida 33319
Not listed Miami Florida 33165
Not listed Orange Park Florida 32073
Investigational Site 112 Pensacola Florida 32504
Not listed Port Saint Lucie Florida 34987
Investigational Site 088 Sarasota Florida 34239
Investigational Site 040 St. Petersburg Florida 33709
Investigational Site 114 St. Petersburg Florida 33713
Not listed Tamarac Florida 33321
Not listed Tampa Florida 33612
Not listed West Palm Beach Florida 33401
Investigational Site 149 Augusta Georgia 30912
Investigational Site 529 Decatur Georgia 30030
Not listed Macon Georgia 31201
Investigational Site 010 Savannah Georgia 31406
Investigational Site 049 Idaho Falls Idaho 83494
Investigational Site 543 Pocatello Idaho 83201
Not listed Evanston Illinois 60201
Not listed Peoria Illinois 61602
Not listed Peoria Illinois 61614
Not listed Anderson Indiana 46011
Investigational Site 101 Iowa City Iowa 52242
Not listed Topeka Kansas 66606
Not listed Louisville Kentucky 40202
Investigational Site 091 Metairie Louisiana 70006
Investigational Site 084 New Orleans Louisiana 70121
Not listed Opelousas Louisiana 70570
Investigational Site 077 Shreveport Louisiana 71101
Not listed Auburn Maine 04210
Not listed Baltimore Maryland 21224
Investigational Site 002 Boston Massachusetts 02215
Investigational Site 035 West Roxbury Massachusetts 02132
Investigational Site 190 Ann Arbor Michigan 48106
Investigational Site 175 Detroit Michigan 48202
Investigational Site 183 Flint Michigan 48504
Not listed Grosse Pointe Woods Michigan 48236
Not listed Kalamazoo Michigan 49007
Not listed Livonia Michigan 48152
Investigational Site 069 Royal Oak Michigan 48073
Not listed Stevensville Michigan 49127
Not listed Troy Michigan 48098
Not listed Butte Montana 59701
Investigational Site 189 Hillsborough New Jersey 8844
Investigational Site 044 Neptune City New Jersey 07753
Not listed Teaneck New Jersey 07666
Not listed Albuquerque New Mexico 27103
Not listed Albuquerque New Mexico 87102
Investigational Site 022 Endwell New York 13760
Not listed Rochester New York 14621
Not listed Rochester New York 14642
Not listed Syracuse New York 13210
Not listed The Bronx New York 10467
Investigational Site 013 The Bronx New York 10468
Investigational Site 146 Asheville North Carolina 28805
Not listed Cary North Carolina 27518
Not listed Charlotte North Carolina 28209
Not listed Hickory North Carolina 28602
Not listed Raleigh North Carolina 27612
Not listed Raleigh North Carolina 48202
Not listed Statesville North Carolina 28625
Not listed Wilmington North Carolina 28401
Not listed Winston-Salem North Carolina 27103
Investigational Site 031 Fargo North Dakota 58104
Not listed Fargo North Dakota 58122
Investigational Site 523 Canton Ohio 44710
Not listed Cincinnati Ohio 45219
Not listed Cleveland Ohio 44106
Investigational Site 129 Cleveland Ohio 44109
Not listed Cleveland Ohio 44118
Investigational Site 003 Columbus Ohio 43215
Investigational Site 061 Dayton Ohio 45419
Not listed Dayton Ohio 45428
Not listed Kettering Ohio 45429
Not listed Marion Ohio 43302
Investigational Site 095 Middletown Ohio 45005
Not listed Bend Oregon 97701
Investigational Site 528 Camp Hill Pennsylvania 17011
Not listed Hershey Pennsylvania 17033
Not listed Philadelphia Pennsylvania 19140
Not listed Pittsburgh Pennsylvania 15212
Not listed Pittsburgh Pennsylvania 15240
Investigational Site 083 Uniontown Pennsylvania 15401
Not listed West Reading Pennsylvania 19611
Investigational Site 020 Wilkes-Barre Pennsylvania 18711
Investigational Site 050 Pawtucket Rhode Island 02860
Not listed Providence Rhode Island 02906
Not listed Providence Rhode Island 02908
Investigational Site 540 Charleston South Carolina 29407
Investigational Site 047 Mt. Pleasant South Carolina 29464
Investigational Site 180 Spartanburg South Carolina 29303
Investigational Site 086 Rapid City South Dakota 57701
Not listed Franklin Tennessee 37067
Not listed Jackson Tennessee 38305
Not listed Nashville Tennessee 37082
Not listed Nashville Tennessee 37203
Investigational Site 544 Austin Texas 78726
Not listed Corpus Christi Texas 78413
Investigational Site 006 Dallas Texas 75216
Investigational Site 119 Fort Worth Texas 76104
Not listed Groesbeck Texas 76642
Investigational Site 193 San Antonio Texas 78229
Not listed Tomball Texas 77375
Investigational Site 135 Orem Utah 84058
Investigational Site 080 Salt Lake City Utah 84124
Investigational Site 012 Lynchburg Virginia 24501
Not listed Williamsburg Virginia 23185
Investigational Site 196 Winchester Virginia 22601
Not listed Spokane Washington 99202
Not listed Tacoma Washington 98405
Investigational Site 030 Marshfield Wisconsin 54449
Not listed Weston Wisconsin 54476

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 193 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01887912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2022 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01887912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →